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Abstract
It has been previously described that p21 functions not only as a CDK inhibitor but also as a transcriptional co-repressor in
some systems. To investigate the roles of p21 in transcriptional control, we studied the gene expression changes in two
human cell systems. Using a human leukemia cell line (K562) with inducible p21 expression and human primary
keratinocytes with adenoviral-mediated p21 expression, we carried out microarray-based gene expression profiling. We
found that p21 rapidly and strongly repressed the mRNA levels of a number of genes involved in cell cycle and mitosis. One
of the most strongly down-regulated genes was CCNE2 (cyclin E2 gene). Mutational analysis in K562 cells showed that the N-
terminal region of p21 is required for repression of gene expression of CCNE2 and other genes. Chromatin
immunoprecipitation assays indicated that p21 was bound to human CCNE2 and other p21-repressed genes gene in the
vicinity of the transcription start site. Moreover, p21 repressed human CCNE2 promoter-luciferase constructs in K562 cells.
Bioinformatic analysis revealed that the CDE motif is present in most of the promoters of the p21-regulated genes.
Altogether, the results suggest that p21 exerts a repressive effect on a relevant number of genes controlling S phase and
mitosis. Thus, p21 activity as inhibitor of cell cycle progression would be mediated not only by the inhibition of CDKs but
also by the transcriptional down-regulation of key genes.
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Introduction
p21CIP1 (p21 herein after) is a member of the Cip/Kip family of
inhibitors of cell cycle progression (also including p27KIP1 and
p57KIP2). The first discovered p21 function and so far its best
studied biochemical activity was the inhibition of cyclin-dependent
kinases [1,2,3,4]. CDKs are protein complexes, composed of a
regulatory cyclin and a catalytic CDK subunit, which orchestrate
cell cycle transitions. Enforced p21 expression results in cell cycle
arrest, which frequently takes place at the G2/M transition and
accompanied by polyploidy [5,6,7,8]. p21 is also a p53 target gene
that plays a relevant role in p53-induced cell cycle arrest [9,10,11].
However, other studies have shown that p21 has activities in
addition to cell cycle arrest. Thus, p21 acts as an inhibitor of
apoptosis induced by DNA-damaging agents [12,13,14] and as
inducer of senescence [15,16,17] or differentiation (reviewed in
[18]). Finally, p21 has been implicated in the control of
transcription, through mechanisms that may be coupled to its
CDK inhibition activity but also by direct association and
modulation of transcription factors. In this way, it has been
demonstrated the interaction between p21 and several transcrip-
tion factors such as CBP, C/EBPa, E2Fs, Myc, Nrf2, STAT3, and
others (reviewed in [19,20,21]). p21 has been found to repress
several genes through the interaction with the E2F transcription
factor [22] or by other mechanisms [15,23,24]. It has also been
described as co-activator of the expression of other genes
[25,26,27,28]. Nonetheless, there is little information on the
biological significance of p21-dependent regulation of gene
expression and to what extent it is linked to effects on the cell
cycle. It has been shown that CDK2 is not an essential target for
p21 in cell cycle inhibition and tumor suppression [29], given
further relevance to the gene regulation effects of p21.
To address the relevance of p21-mediated gene regulation we
have carried out large-scale expression profiling in two different
human systems (keratinocytes and myeloid leukemia cells) upon
ectopic expression of p21. p21 provokes a rapid and potent down-
regulation of genes involved in the execution and control of mitosis
in both models. Mutational analysis revealed that the N-terminal
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region of p21 is required for its transcriptional effects in leukemia
cell. CCNE2 (cyclin E2) is one of the most potently down-regulated
genes and p21 was found to bind and repress the human CCNE2
promoter.
Methods
Cell culture, transfection, viral infection
Primary human keratinocytes wereprepared from discarded
human tissue, mostly from reduction abdominoplasties, with
Institutional Review Board approval (MGH#2000-P-002418/3)
and were grown as described [30]. K562 are human chronic
myeloid leukemia cells, and were purchased from ATCC. Kp21-4
cells are K562 carrying a Zn2+ -inducible p21 gene; Kp27-5 cells
are K562 carrying a Zn2+ -inducible p27 gene [31]. K562 and
derivatives were grown in RPMI with 8% fetal calf serum.
Adenovirus infections of keratinocytes were performed for 1 h in
serum and epidermal growth factor-free-low calcium medium as
previously described [32]. Keratinocytes were then incubated in
fully supplemented medium for 24 h prior to collection for RNA
analysis. Adenoviruses expressing full-length, N-terminal, C-
terminal p21, p16, and p27 have been previously reported [32].
For transient transfections of K562, ten millions of cells were
transfected with 12 mg of p21-WT-GFP, p21-CT-GFP and p21-
NT-GFP expression vectors, as well as the GFP empty vector [33]
using Lipofectamine 2000 (Invitrogene). 12 h after transfection,
GFP-expressing cells were harvested by flow cytometry (FACSAria
cell sorter, BD Biosciences). For transient transfections of Kp21-4,
one million cells were electroporated with 2 mg pLKO-shCDK2
(Open Biosystems) or pLKO.1 using an Amaxa nucleofector (kit
V). 24 h after transfection ZnSO4 was added (75 mM), the cells
were further incubated for 12 h and harvested.
Flow cytometry
One million cells per sample were fixed with 80% ethanol and
stained with propidium iodide as described previously [31]. Cells
were analysed by flow cytometry on a FACScant (BD Biosciences).
Ten thousand events were gated and analysed using CellQuest
software (BD Biosciences).
siRNA transfection
Human primary keratinocytes were transfected with 200 nM
siRNAs for CDKN1A gene (p21) (Stealth RNAi, Invitrogen) and
control siRNAs (Stealth RNAi negative control, Invitrogen) using
Lipofectamine 2000 following the manufacturer’s recommenda-
tions. 48 h after transfections, cells were analyzed by RT-qPCR
(reverse transcriptional-quantitative polymerase chain reaction)
mRNA determination
Total RNA was isolated using TriReagent (Molecular Research
Center) kit (Qiagen). Reverse transcription (RT) was performed
with iScript reverse transcriptase (BioRad). Quantitative PCR
(qPCR) was performed with the SYBRGreen PCR kit (BioRad) in
a BioRad MyiQ apparatus. Primers sequences and amplicon sizes
used in the RT-qPCR assays are shown in Table S1. Data were
normalized to ribosomal protein S14 (RPS14) mRNA levels.
Gene expression profiling
Total RNA was prepared using RNeasy kit (Qiagen). Biotini-
lated cRNA was obtained from total RNA and hybridized to
Affymetrix HG-U133A chip in the Genomic Facility of Centro de
Investigación del Cancer (Salamanca, Spain). Data analysis and
hierarchical tree clusters were generated using the dChip software
[34], http://biosun1.harvard.edu/complab/dchip/]. The expres-
sion data was filtered so as to include genes with expression
changes $2.4-fold. The data were obtained in compliance with
the MIAME guidelines and are deposited in the ArrayExpress
database. The accession numbers are E-MEXP-3431 for the
expression data with Kp21-4 and Kp27-5 cells and E-MEXP-3430
for expression data of human keratinocytes. The analysis was
performed with data from two independent experiments and RNA
preparations of each experimental condition or adenoviral
infection. The interaction network for differentially expressed
genes was generated with the Ingenuity Pathways Analysis
software.
Immunoblotting and cell extract fractionation
Total cell lysates and immunoblots were carried out as
described [31]. Blots were developed with secondary antibodies
conjugated to IRDye680 or IRDye800 (Li-Cor Biosciences) and
visualized in an Odyssey scanner. Antibodies used were anti-p21
(C-19), anti-UBF (F5), anti-CDK2 (M2) and anti-a-tubulin (H-
300). All were polyclonal antibodies from Santa Cruz Biotech. The
isolation of chromatin fraction was performed essentially as
described [35]. Briefly, the cells were lysed for 20 min with
agitation at 4uC in CSK buffer (10 mM HEPES pH 7.5, 100 mM
NaCl, 300 mM sucrose, 3 mM MgCl2, 0.5% Tritón X-100 and
protease inhibitors). After centrifugation the supernatant was
collected as cytoplasmic plus nucleoplasmic fraction. The pellet
was washed at maximum setting with CSK buffer, resuspended in
CSK buffer, sonicated and saved as chromatin fraction.
Chromatin Immunoprecipitation (ChIP) assays
ChIP analysis was carried out as described previously [36].
Briefly, 10 millions of K562, Kp21-4 and Kp27-5 cells were fixed
with formaldehyde and lysed in SDS lysis buffer. Cross-linked
chromatin was fragmented by sonication to an average size of
400 bp. Chromatin was then immunoprecipitated with anti-p21
(C-19, Santa Cruz Biotechnology), anti-p27 (C-19, Santa Cruz
Biotechnology), anti-CDK2 (M2, Santa Cruz Biotechnology), anti-
histone H3 (FL-136, Santa Cruz Biotecnology) and anti-acetylat-
ed-histone H3 (06-559, Millipore). Antibodies and cell lysates were
incubated overnight at 4uC, and then with protein G-coupled
magnetic beads (Dynabeads, Invitrogen) for 1 h at 4uC. Controls
were performed by incubating parallel samples with non-immune
IgG. The protein-DNA cross-links were reversed by 4 h incuba-
tion at 65uC, and immunoprecipitated DNA was analyzed by
quantitative PCR using a BioRad MyiQ apparatus. The signals
were normalized to the inputs and the signals obtained with
normal rabbit IgG (Santa Cruz Biotechnology) The primers used
for PCR reactions are indicated Table S1.
Luciferase reporter assays
Two million of cells were electroporated with 15 mg of pCyCE1-
Luc [37,38] carrying a fragment of the human CCNE1 and
CCNE2 promoters, respectively, upstream of the firefly luciferase.
These luciferase reporters were co-transfected with pCEFL or
pCEFL-p21 [39]. Cells were electroporated with the reporters and
expression vectors (15 mg) at 260 v and 975 mFa in a BTX
electroporator. 24 h alter transfection the cells were treated with
75 mM ZnSO4 for another 24 h. Luciferase activity was then
determined with Lysis Solution 1 (Promega), Luciferase Substrate
(Promega) and a GloMax 20/20 luminometer (Promega), follow-
ing the manufacturer’s instructions. All transfections were
normalized by measuring b-galactosidase activity of the samples.
Data are the average of at least three independent experiments
and error bars indicate standard deviation.
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Results
p21 represses mitotic genes in human leukemia cells
In order to find genes regulated by p21 in human primary cells
we carried out a gene expression profiling in human myeloid
leukemia K562 cells with conditional expression of p21. We
previously described a K562 derivative, termed Kp21-4, that
carries a zinc-inducible p21 gene [31]. We performed a kinetic
study to identify the expression peak of p21 in this system. The
immunoblot results showed that treatment of Kp21-4 cells with
75 mM ZnSO4 resulted in induction of p21 that peaked 4–12 h
decreasing afterwards (Figure 1A). This transient induction of p21
was accompanied by proliferation arrest and an increase in
polyploid cells after 48–72 h [31]. The cell cycle profile did not
change over the first 12 h of p21 induction with ZnSO4 but 6–
12 h of p21 induction were sufficient to irreversibly trigger
proliferation arrest and polyploidy (Figure S1). Therefore, we
chose 12 h as the induction time to analyse p21 effects on the
transcriptome of these cells, as gene expression changes later on
may be indirect due to other phenotypic effects.
We next carried out the gene expression profiling of Kp21-4
cells upon p21 induction by ZnSO4. In order to identify genes
specifically modulated by p21 we compared with the cell line
Kp27-5, which carries a Zn2+-inducible p27 allele [31]. p27 is a
close relative to p21 that also inhibits CDKs and induce cell cycle
arrest [40]. Thus, the comparison serves to identify genes
specifically regulated by p21 in our analysis. We subtracted the
gene expression changes occurring at 72 h in Kp21-4 cells those
genes regulated by p27 in the Kp27-5 cells and genes changed by
ZnSO4 treatment in parental K562 cells. We found 350 genes
whose expression changed $2.3 fold in Kp21-4 after 12 h of p21
induction and which were not regulated at this time point in
Kp27-5 or K562 cells treated with ZnSO4 (Figure 1B). The list of
the genes with their corresponding expression change is shown in
the Table S2.
The dataset used for the clustering analysis of Figure 1B was
further analyzed with the Ingenuity Pathways software to reveal
the network of interactions between differentially regulated genes.
The results showed that the two highest-ranked networks were
assembled by interactions between genes related to cell cycle
control (Figure S2). Gene ontology analysis revealed that cell cycle-
related genes accounted for about one fifth of the regulated genes,
i.e., 65 genes (Figure 1C). The expression change of these genes is
shown as a heat map in Figure 1D, demonstrating that the vast
majority of these genes were down-regulated by p21. The former
result defined cell cycle and mitosis as the most relevant functional
categories of p21-down-regulated genes. We investigated the
kinetics of changes in the RNA levels of 19 genes repressed by p21
from those appearing in Figure 1D plus BIRC5, CCNB1 and CDK2,
because of their involvement in cell cycle. RNA was prepared from
Kp21-4 cells and expression was determined by RT-qPCR at
different periods of time up to 12 h after ZnSO4 addition, i.e.,
when p21 expression is maximal and its effect is already
irreversible. The results are shown in Fig. 2A and confirmed that
most of the down-regulated genes identified by microarray
hybridization were down-regulated as soon as 6 h after the
addition of the p21 inducer. ZnSO4 did not modify the expression
of any of these genes in parental K562 (data not shown). To
confirm the repressive effect of p21 we analyzed the level of
acetylated-histone H3, a marker of active chromatin [41], in the
chromatin region corresponding to the transcriptional start site of
several genes. The results showed a dramatic decrease in the
fraction of acetylated-histone H3 as soon as 6 h after p21
induction (Fig. 2B). The data also argues that the decrease in
mRNA levels is caused by transcriptional switch-off rather than
mRNA degradation
The fast kinetics of gene down-regulation caused by p21, before
any change in cell cycle profile could be detected, suggested that
the repression is a direct consequence of p21 activity, rather than
an indirect effect. CDK2 inhibition is the best known biochemical
activity of p21, and it also occurs in K562 [31]. Thus, we explored
the possibility that the p21-dependent gene expression regulation
described above is a consequence of CDK2 inhibition. We
conducted two sets of experiments. First, we showed that the
depletion of CDK2 in Kp21-4 cells achieved through siRNA did
not modify the p21-dependent repression of the assayed genes.
This has been demonstrated by transient expression of a short-
hairpin CDK2 vector (Fig. 3). Second, we analysed the effects of
p27, which also provokes CDK2 inhibition and cell cycle arrest
[31], on the expression of genes down-regulated by p21. In
contrast to p21, p27 provoked a dramatic G1 arrest already
detectable after 6 h of induction in Kp27-5 cells (Figure S1). p27
was induced in Kp27-5 cells for 3–12 h and the expression of 11
genes was assayed by RT-qPCR. The results showed that p27 did
not repress cell cycle genes or repressed them with a much slower
kinetics than p21 (Figure S3), despite a similar induction level of
p21 and p27 in p21-4 and Kp27-5 cells respectively (Figure S1A).
Moreover, we performed gene expression profiling in Kp27-5 cells
upon 12 h of p27 induction. The results showed that at this
induction time p27 elicited weaker effects on gene regulation than
p21. After subtraction of p21-regulated genes the analysis revealed
that p27 regulated only 180 genes (with an expression change
$2.3 fold after 12 h of p27 induction) and none of them was
annotated as related to cell cycle, according to the Gene Ontology
analysis (Figure S4). The comparison to retrieve shared gene
expression profiles by p21 and p27 induction revealed 90 common
genes that were regulated by both proteins after 12 h of induction.
These genes belong to different functional categories, but only 8
genes were related to cell cycle (Figure S4).
The N-terminal region of p21 is sufficient for gene down-
regulation
Next, we asked whether the CDK-cyclin binding domain of p21
was involved in the down-regulation of gene expression. We used
two p21 deletion constructs carrying the green fluorescent protein.
One construct carried the first 91 amino acids, which included the
CDK-cyclin binding region and the second construct the C-
terminal region, after the codon 91 [33] (Figure 4A). Although the
GFP-N-terminal construct lacked the nuclear localization signal in
the p21 region, it partly localizes in the cell nuclei, likely due to the
GFP domain [33]. We transfected these constructs as well as the
full-length p21-GFP construct and selected the GFP-expressing
cells by fluorescent-activated cell sorting. We further tested the
expression of several genes with rapid (CCNE2, KIF4A) and slower
(WEE1) down-regulation kinetics (see Figure 2). The expression of
CCNE2, WEE1 and KIF4A in GFP-positive cells was determined
by RT-qPCR in the transfected cells. The results showed that the
N-terminal p21 was sufficient to provoke the gene down-
regulation, although it was a less efficient repressor than the full-
length p21. In contrast, C-terminal p21 was inactive as repressor
of the assayed genes (Figure 4B).
This indicates that the repressive activity of p21 is independent
of the protein-protein interaction domain known to reside in the
C-terminal region, as PCNA binding [42].
p21 binds to the human CCNE2 promoter
The observation that p21 provokes a rapid mRNA repression of
various genes, suggested that p21 might participate in gene
p21 as Repressor of Cyclin E2 and Mitotic Genes
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Figure 1. Gene expression changes induced by p21 in K562 cells. A. Expression of p21 in Kp21-4 cells in response to ZnSO4. Cells were
treated with 75 mM ZnSO4 for the periods of time indicated. Cell extracts were prepared and the p21 levels analyzed by immunoblot. B. The
transcriptome of Kp21-4 cells (Kp21) treated for 12 h with ZnSO4 (to induce p21) were compared to that of cells with induced p27 (Kp27), parental
K562 and Kp21-4 treated for 72 h with ZnSO4. The heat map shows the hierarchical clustering with those genes with expression variation $2.3-fold
between uninduced and p21-induced Kp21-4 cells (P,0.001). The heat map shows 350 regulated genes (360 gene probes). C. Distribution of the
regulated genes shown in A according with their cell functions. The ontogeny analysis has been carried out with the dChip program. D. Expression
changes in 65 genes related to cell cycle and mitosis according to the ontogenic classification. The heat map was obtained as described in B. The
genes further validated by RT-qPCR (Figure 2A) are shown in red.
doi:10.1371/journal.pone.0037759.g001
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Figure 2. p21-mediated the down-regulation of genes involved in cell cycle. A.The expression of p21 was induced in Kp21-4 cells by 75 mM
ZnSO4 and 3, 6 and 12 h later, total RNA was prepared and expression of the indicated genes was determined by RT-qPCR. In some cases an
alternative name is given into brackets. Cyc., cyclin. The values are means 6S.E.M. from two independent experiments and two determinations for
each RNA. B. Kp21-4 cells were treated for 6 h with 75 mM ZnSO4 to induce p21. Chromatin immunoprecipitation was carried out with anti-histone H3
and anti-acetylated-histone H3 antibodies and (as specificity control) rabbit IgG. The DNA in the immunoprecipitated chromatin was measured by
quantitative PCR. The amplicons encompass the transcription start site of the indicated genes. A regulatory sequence of the promoter of rDNA was
used as a control. The results are expressed as the ratio of DNA enrichment in chromatin immunoprecipitated with anti-H3 versus acetylated-H3 (‘‘Ac-
H3’’) and normalized to the values obtained in uninduced cells. The values are the means 6S.E.M of two independent ChIP experiments with two PCR
determinations each.
doi:10.1371/journal.pone.0037759.g002
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repression as a transcriptional modulator, a function already
reported for p21 (see Introduction). For further analysis, we
focused on the CCNE2 gene because of its pivotal role in S phase
entry and because it showed one of the fastest down-regulation
kinetics, with a decrease as soon as 6 h after Zn2+ addition
(Figure 2). We previously reported that most p21 remains nuclear
upon induction with Zn2+ in Kp21-4 cells [43]. However, in order
to act as co-regulator it is required that at least part of the p21
induced by Zn2+ in Kp21-4 cells is bound to chromatin. We first
carried out a fractionation of Kp21-4 nuclear extracts into
chromatin and nucleoplasmic fractions. The results of the
immunoblot show a significant amount of p21 bound to the
chromatin fraction in Kp21-4 cells induced with ZnSO4
(Figure 5A). This result led us to ask whether p21 could be bound
to the promoter of their regulated genes. We performed chromatin
immunoprecipitation (ChIP) in Kp21-4 cells with anti-p21
antibody, and asked for p21 binding in the vicinity of the
transcription start site (TSS) of human CCNE2 and other p21-
repressed genes. The results showed that p21 was bound to the
region encompassing the TSS in Kp21-4 cells upon p21 induction
after 12 h of treatment with ZnSO4 (Figure 4B). We also found
p21 binding to the promoters of other p21-target genes as CDK2,
KIF4A, PLK1 and WEE1 to similar extent than to CCNE2
promoter (Figure 5B). As additional controls, we performed ChIP
experiments in Kp27-5 cells treated with ZnSO4 to induce p27
[31] and in parental K562 also treated with ZnSO4. No
enrichment was found in the chromatin precipitated with anti-
p21 in both cases. Also, no specific signal was detected with anti-
p27 antibody in Kp21-4 cells and in Kp27-5 cells with induced
p27 expression (Figure 5B). As the p21 region required for
repression includes the cyclin-CDK binding region (Figure 4) we
also performed ChIP assays with anti-CDK2 antibody. The results
show that in cells overexpressing p21, CDK2 is recruited to the
same site of human CCNE2 that p21 (Figure 4B), which is in
concordance with the presence of p21 on that region of the
chromatin.
p21 represses CCNE2 promoter activity
The former results show that CCNE2 is rapidly down-regulated
by p21 and that p21 is bound to CCNE2 proximal promoter in
Kp21-4 cells. To confirm the hypothesis that p21 may act as a
transcriptional modulator we carried out luciferase assays with
reporters harbouring the human CCNE2 and (as a control) CCNE1
promoters. The results demonstrated a modest but significant and
reproducible decrease in CCNE2 promoter upon transfection of a
p21 expression vector (Figure 6A). As a second approach, we next
used the Kp21-4 cell line and performed the luciferase assays 24 h
after the induction of p21 (Figure 6B). Immunoblot analysis
revealed the overexpression of p21 in transfected cells (Figure 6A
and 6B, lower panels). Taken collectively the results strongly
Figure 3. p21-mediated repression of genes is not dependent on CDK2. A. K562 cells were transiently transfected with a short-hairpin CDK2
(‘‘shCDK2’’) vector and the empty vector (pLKO.1, ‘‘Vo’’). 24 h after transfection the cells were treated with 75 mM ZnSO4 for 12 h to induce p21 and
the silencing of CDK2 was assayed at the protein level by immunoblot (left panel) and at the mRNA level by RT-qPCR (right panel) The expression of
p21 and actin was also determined to control the p21 induction by Zn2+ and the protein level, respectively. B. The expression of p21 was induced
with 75 mM ZnSO4 in K562 transfected with sh-CDK2 and 12 h later, total RNA was prepared and expression of the indicated genes was determined
by RT-qPCR. The values are means 6S.E.M. from two independent experiments and two determinations for each RNA.
doi:10.1371/journal.pone.0037759.g003
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suggest a role of p21 in the negative regulation of CCNE2 and
other genes in the K562 system.
p21 represses mitotic genes in human primary
keratinocytes
All the previous results have been obtained in a cell line derived
from human myeloid leukemia. In order to confirm these results
we studied the p21-dependent repression of mitotic genes in a
different cellular system. We chose human primary keratinocytes
because they are non-tumorigenic, non-immortalized and epithe-
lial cells, in contrast to K562 cells. Human primary keratinocytes
were infected with recombinant adenoviruses expressing the full-
length p21 protein. A dramatic increase in p21 in infected
keratinocytes was demonstrated by RT-qPCR (Figure 7A). As
controls, we also infected the keratinocytes with adenovirus
carrying the genes for p27, which overexpression was also
confirmed by RT-qPCR (Figure 7A). We prepared RNA 24 h
after infection and performed large-scale expression assay using
the Afftymetrix platform. The clustering analysis revealed that p21
provoked the down-regulation of a number genes involved in cell
cycle control not shared by cells expressing p27 (Figure 7B). The
list of the genes with their corresponding expression change is
shown in the Table S3. We next validated by RT-qPCR the p21-
mediated repression of several of these genes involved at various
checkpoints of cell cycle (AURKB, BIRC5, CDC25C, CCNE2 and
WEE1). The results demonstrated the decreased levels of mRNA
for all the tested genes, confirming the data of the microarray
hybridization (Figure 8A). To fully confirm the effect of p21 as a
repressor of these genes in keratinocytes, we silenced p21 through
siRNA transfection (Figure 8B). The expression of the five genes
was tested in p21-depleted cells and we found that the five genes
were up-regulated to various extents (Figure 8C). The results
therefore confirm the regulation of the expression of the analyzed
genes by p21.
Bioinformatic analysis of p21-targeted genes
As noted in the Introduction, it has been reported that p21
binds to specific DNA sequences of some p21-regulated genes. As
p21 lacks any recognizable DNA-binding domain, the interaction
must be indirect, i.e., through another transcription factor or co-
factor. We previously reported that p21 can bind genes at E2F-
Figure 4. The N-terminal region of p21 is required for its effect as gene repressor. A. Schematic representation of the p21 constructs used.
The proteins carry the green fluorescent protein (GFP) in the N-terminal. The position of the CDK binding domain (CDB) and the PCNA binding
domain (PCNA) are indicated. B. K562 cells were transfected with expression vectors for the full-length p21 protein (FL), the p21 amino-terminal
region (NT) and the p21 carboxy-terminal region (CT). 24 h after transfection the cells were sorted by flow cytometry and the expression of the
indicated genes was analysed by RT-qPCR. The values are means 6S.E. from two transfections and two determinations of each mRNA.
doi:10.1371/journal.pone.0037759.g004
p21 as Repressor of Cyclin E2 and Mitotic Genes
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Figure 5. p21 binds to human CCNE2 promoter. A. Kp21-4 cells were treated for 12 h with ZnSO4 and the nuclear extracts were fractionated
between insoluble (chromatin) fraction and soluble (nucleoplasmic) fraction. The p21 levels were determined by immunoblot. The transcription factor
UBF was used as control of chromatin-bound protein. B. Cells were treated for 12 h ZnSO4 to induce p21 (in Kp21-4 cells), p27 (in Kp27-5 cells),
parental K562 cells were also treated with ZnSO4 as negative control. Chromatin immunoprecipitation was performed with anti-p21, anti-p27 and
anti-CDK2 antibodies as indicated, and (as specificity control) rabbit IgG. The DNA in the immunoprecipitated chromatin was analysed by quantitative
PCR. The amplicons encompass the transcription start site of the indicated genes. rRNA promoter sequences were used negative controls. The results
are expressed as enrichment of DNA in chromatin immunoprecipitated with anti-p21 (with respect the signal with anti-rabbit IgG) in cells induced
with Zn2+, and normalized to the values obtained in uninduced cells. The values are the means 6S.E.M of three PCR determinations, each from two
independent ChIP experiments.
doi:10.1371/journal.pone.0037759.g005
Figure 6. p21 represses the activity of human CCNE2 promoter. A. K562 cells were transfected with luciferase reporters carrying the
promoters cyclin E1 and E2 genes (CCNE1 and CCNE2), along with an expression vector for p21 and the corresponding empty vector, and a beta-gal
plasmid for transfection efficiency normalization. 24 h after transfection the luciferase activities were determined. The data are normalized to the
activity of cells transfected with the empty vector. Lower panel: immunoblot analysis of the transfected cells to assess the expression of p21. B. Kp21-
4 cells were transfected with luciferase reporters carrying the promoters cyclin E1 and E2 genes as in (A) and 24 h later the cells were treated with
75 mM ZnSO4 and after 24 h the luciferase activities were determined. The data are normalized to the activity of cells without ZnSO4. Lower panel:
immunoblot analysis of the transfected cells to assess the expression of p21.
doi:10.1371/journal.pone.0037759.g006
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Figure 7. Genes regulated by p21 in human keratinocytes related to cell cycle and cell division. A. Primary human keratinocytes were
infected with recombinant adenoviruses expressing p21 (Ad-p21), p27 (Ad-p27). As a control, cells were also infected with adenovirus expressing GFP
(Ad-GFP). The mRNA expression of p21 (upper graph) and p27 (lower graph) was determined by RT-qPCR 24 h after infection. Data are represented
relative to the expression in Ad-GFP-infected cell. B. Heat-map showing the 82 genes changed by p21 related to cell cycle and cell division with an
expression change . 2.3-fold. The names of the regulated genes are indicated at the right. Green indicates genes down-regulated by p21 and red
genes up-regulated.
doi:10.1371/journal.pone.0037759.g007
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binding elements [23]. Another report showed the binding of p21
to the CDE/CDH element, composed by the the cell cycle-
dependent element (CDE) and the cell cycle genes homology
region (CHR) [44]. Therefore, we have performed a bioinformatic
analysis of the promoters of the 22 genes where p21-mediated
down-regulation was validated by RT-qPCR (shown in Figure 2).
The results show that a majority of the genes carried several E2F
sites in the 59 regulatory region and/or the first exon (Figure 9) but
there were some exceptions (BIRC5, CCNB2, DHFR, KIF4A). More
interestingly, all genes but one (BUB1) contained at least one CDE
site in the vicinity of the TSS (Figure 9). In this context it must be
noted that human CCNE2 promoter and first exon are particularly
rich in CDE sequences. Thus, p21 may impair transcription of
genes in charge of the execution and control of mitosis through the
interaction with transcription factors binding to CDE or CDE/
CHR motifs.
Discussion
Despite the original description of p21 as a CDK inhibitor, a
number of reports have described a role of p21 as transcriptional
modulator for different genes such as WNT [23], cyclin D1 [27],
polo-like kinase 1 (PLK1), topoisomerase IIa [44], CDC25A, MYC
[24] and p53 [45]. p21 has also been described as an antagonist of
E2F-dependent transcription [22]. Conversely to previous studies,
we have analyzed the genome-wide p21-dependent gene regula-
tion in two different human cellular models: a myeloid leukemia
cell line (K562) and primary keratinocytes. p21 overexpression was
attained through the induction of a conditional transgene by
ZnSO4 (in human myeloid cells) or through acute adenoviral
infection (in human keratinocytes).
Our results on the gene expression profiling in both cell models
showed that p21 provokes a rapid repression of mRNA of genes
involved in cell cycle and mitosis control in the two models. Since
p21 elicits cell growth arrest this effect could be indirect, i.e., a
consequence of the cell cycle arrest. However, in myeloid cells with
inducible p21 (Kp21-4 cells), the kinetics of the mRNA down-
regulation of most of the analysed genes was almost parallel to the
kinetics of the p21 protein up-regulation. This down-regulation of
mRNA was also concomitant with the rapid deacetylation of
histone H3 at the TSS. The genes repressed by p21 were up-
regulated upon p21 silencing, confirming the p21 activity.
Moreover, the early p21-induced down-regulation was not
reproduced by p27 induction in K562 cells form most genes,
despite that p27 also provokes a cell cycle arrest via CDK
inhibition. Furthermore, the depletion of CDK2 does not affect
the p21-mediated gene repression. Altogether these data argue
against the idea that the p21 effects were a direct consequence of
the CDK inhibition or of the cell cycle arrest. Thus, it is
conceivable that p21 is directly involved in transcriptional
repression of a set of genes involved in cell cycle control. Previous
unsuccessful attempts to generate a functional p21 fused to the
estrogen receptor (so as to get activated by tamoxifen) [46]
precluded the analysis of p21 transcriptional effects in the absence
of protein synthesis.
It is remarkable the similarity in the short-term transcriptional
effects of p21 overexpression observed in two very different cell
types (keratinocytes and myeloid cells), despite the different long-
term consequence of p21 overexpression in each cell type. p21
inhibits epidermal differentiation in keratinocytes [25,32] whereas
it induces polyploidy and megakaryocytic differentiation in K562
[31]. It is of note however, that the transcriptional changes that we
have observed occur before any phenotypic change can be
detected in either cell line. In Kp21-4 cells, the polyploidy is
detectable 3–4 days after induction and at this time point, the
expression of CDC25, cyclin A and cyclin E are recovered, likely
to allow DNA synthesis for endoreplication [8]. Previous studies in
a fibrosarcoma cell line also showed p21 repressed genes involved
in mitosis followed by polyploidy three days after p21 induction
[7], suggesting that polyploidization may be a common effect of
p21 in tumor cells.
We further analysed the regulation of CCNE2 (cyclin E2), one of
the genes undergoing a fastest down-regulation. ChIP assays
revealed that p21 binds in the vicinity of the TSS of human cyclin
E2 gene (as well as other four genes: CDK2, KIF4A, PLK1 and
WEE1). The results are consistent with previous literature showing
Figure 8. p21-mediated down-regulation of genes involved in
mitotic control in human keratinocytes. A. Primary human
keratinocytes were infected with adenovirus expressing p21 and ad-
GFP as a control. 24 h after infection total RNA was prepared and the
mRNA levels of the indicated genes were analysed by RT-qPCR. The
values are means 6S.E. from three determinations. B. keratinocytes
were transfected with siRNA for p21 and a negative control siRNA. Total
RNA was prepared and the mRNA levels of the indicated genes were
analysed by RT-qPCR. C. Primary human keratinocytes were transfected
with p21 siRNA or control siRNA. 48 h after lipofection total RNA was
prepared and the mRNA levels of the indicated genes were analysed by
RT-qPCR.
doi:10.1371/journal.pone.0037759.g008
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chromatin binding of p21 in several models (see Introduction). In
contrast, upon induction of p27 for 12 h in Kp27-5 cells, we could
not detect significant binding of p27 to CCNE2 promoter.
In full agreement with the results observed at the mRNA level
and ChIP assays, luciferase reporter experiments showed that p21
repressed the human CCNE2 promoter. The mutational analysis
revealed that CCNE2 gene repression depends on the N-terminal
region of p21, i.e., the region involved in the binding to cyclin-
CDK complexes. The C-terminal domain of p21 is not required,
but seems to contribute for full activity of p21 as repressor. It is
noteworthy that p21 does not repress CCNE1 promoter (if it does)
as efficiently as CCNE2, arguing for a differential role of both
cyclins.
Taken together the data argue for a role of p21 as co-repressor
of gene transcription for genes related to cell cycle. As p21 lacks
any recognizable DNA-binding domain, the interaction must be
indirect, i.e., through another transcription factor or co-factor. It
has been reported that p21 binds to specific DNA sequences of
some genes. For instance, we have previously shown that this is the
case for WNT4 repression, which depends on the interaction with
E2F1 [23]. Also, it has been reported that p21 repress the mitotic
control gene PLK1 through binding to the CDE/CHR element
[44]. The CDE/CHR elements control the transcription of genes
with maximum expression in G2 phase and in mitosis and are
repressed in G0 and G1 phases, although the transcription factor(s)
responsible are still unidentified [47]. It has been recently reported
that p27 binds to some promoters through E2F4 sites in mouse
fibroblasts [48]. Our analysis showed that many of the p21-
downregulated genes contained one or several E2F binding sites,
but at least four genes did not (BIRC5, CCNB2, DHFR, KIF4A),
Figure 9. Putative regulatory sites in genes down-regulated by p21. Schematic representation of the E2F (red), CDE (blue) and CDE/CHR
(green) sites in the p21-regulated genes analysed in Figure 2. The region analysed encompass 2 kb upstream and downstream the transcription start
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despite that a relaxed consensus sequence as E2F’s binding site was
used for the analysis, which includes E2F4 sites (Figure 9). Our
analysis does not give information regarding the specific E2F
family member involved, so the differential binding of E2F factors
on the different genes is an open possibility. More interestingly, we
found that all genes but one (BUB1) contained at least one CDE
site in the vicinity of the TSS. In this context it must be noted that
human CCNE2 promoter and first exon are particularly rich in
CDE sequences. Thus, p21 may impair transcription of genes in
charge of the execution and control of mitosis through the
interaction with transcription factors binding to CDE or CDE/
CHR motifs.
Altogether, our results indicate that p21 is a multifunctional
protein with the capacity to act through at least two mechanisms
to control cell cycle: directly inhibiting CDKs and indirectly
regulating genes involved in cell cycle control. The relative
importance of each mechanism await further investigation, but it is
of note that p21 is able to arrest the cell cycle in CDK2-deficient
cells [29], arguing for the importance of transcriptional repression
in the p21 functions in cell biology. Additional studies are required
to dissect out the mechanisms involved in the transcriptional
repression mediated by p21.
Supporting Information
Figure S1 Cell cycle alterations mediated by p21 and p27 in
K562 cells. A. Immunoblots showing the induction of p21 in
Kp21-4 cells and p27 in Kp7-5 cells after 6 and 12 h of treatment
with 75 mM ZnSO4. B. Absence of cell cycle profile alteration after
short induction times of p21. Cell cycle profile of Kp21-4 and
Kp27-5 cells upon induction of p21 and p27 with 75 mM ZnSO4
for 6 and 12 h. The cell cycle profile was determined by flow
cytometry of propidium iodide-stained cells. C. p21 induces an
irreversible accumulation of G2 and polyploid cells whereas p27
induces a reversible accumulation in G1. Kp21-4 and Kp27-5
were treated with ZnSO4 for 12 h. The cells were then washed to
remove the inducers, further incubated for 84 h and the cell cycle
profile was determined by flow cytometry (4 days after the
induction). The fraction of cells in G1, G2 or polyploidy cells
(.G2) is indicated in each case.
(TIF)
Figure S2 Interaction networks of genes regulated by p21 in
K562 cells. A knowledge-based database (Ingenuity Pathways
Analysis) was seeded with the genes regulated by p21 at 12 h of
induction (Table S2). The two networks with the highest score are
shown. The program processed 279 genes (137 up-regulated, 142
down-regulated). The ontogeny category of the networks is as
indicated at the bottom. Genes in red were up-regulated and those
in green were down-regulated. The meanings of node shape and
lines are indicated at the bottom.
(TIF)
Figure S3 Comparison of the gene regulation mediated by p21
and p27 in K562 cells. p21 was induced in Kp21-4 cells and p27
was induced in Kp27-5 cells by 75 mM ZnSO4. After 3, 6 and 12 h
of induction, total RNA was prepared and expression of the
indicated genes was determined by RT-qPCR. The data for
Kp21-4 cells are the same than in Figure 2. The values are means
6S.E.M. from two independent experiments and two determina-
tions for each RNA
(TIF)
Figure S4 A. Gene expression regulation mediated by 12 h
induction of p27 in K562 cells. The transcriptome of Kp27-5 cells
(Kp27) treated for 12 h with ZnSO4 (to induce p27) were
compared to that of cells with induced p21 (Kp21) and parental
K562 treated for 12 h with ZnSO4. The heat map shows the
hierarchical clustering with those genes with expression variation
$2.3-fold between uninduced and p27-induced Kp27-5 cells after
subtraction of the gene expression changes due to p21 in Kp21
cells(P,0.001). The heatmap shows 179 genes. B. Common genes
regulated by both p21 and p27 in K562 cells. Kp21-4 and Kp27-5
cells were treated for 12 h with 75 mM ZnSO4 to induce p21 and
p27 respectively. The heat map shows the hierarchical clustering
with those genes with expression variation $2.3-fold between
uninduced cells and Zn2+ –treated cells which are regulated in
both cell lines(P,0.001). The heat map shows 90 genes. The genes
related to cell cycle according with Gene Ontology are shown in
red.
(TIF)
Table S1 Primers used in PCR reactions in this work. The
forward primer is in the first line. All correspond to human genes
except GFP (Green Fluorescent Protein from Aequorea victoria,
encoded in the plasmid pEGFP-C1). An alternative common
name of the gene is included for some genes.
(DOC)
Table S2 Genes regulated by p21 in K562 cells. The table list
the genes showing an expression change in Kp21-4 cells treated
with ZnSO4 (p21 inducer) for 12 h, after subtracting those genes
changed by ZnSO4 in parental K562 cells (i.e., changed by
ZnSO4) and in Kp27-5 cells (i.e., induced by p27). The 253 genes
are included in the heat map of Fig. 1B. The table includes genes
with ID and with a fold change $log21.2 ($2.3-fold) and with a
signal difference $50 between both experimental conditions (as
defined by dChip program and with Affymetrix U133 biochip
data). Values are mean of fold changes (expressed as log2) of two
independent experiments (P,0.001). For those genes represented
by two or three Affymetrix probes, the fold change is the mean
between the values of the probes. A negative fold change indicates
down-regulation upon p21 induction.
(DOC)
Table S3 Genes regulated by p21 in primary keratinocytes. The
table list the genes showing an expression change in human
primary keratinocytes infected with adenovirus-p21 as described in
Methods. RNA was analysed 24 h after infection. The 75 genes
are included in the heat map of Fig. 7. The table includes genes
with a fold change $log21.2 ($2.3-fold) and with a signal
difference $50 between both experimental conditions (as defined
by dChip program and with Affymetrix U133 biochip data).
Values are mean of fold changes (expressed as log2) of two
independent experiments (p,0.001). For those genes represented
by two or three Affymetrix probes, the fold change is the mean
between the values of the probes. A negative fold change indicates
down-regulation upon p21 induction.
(DOC)
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